Dr. Farshid Y. Araghizadeh, MD

Dr. Araghizadeh practices at Medical City Surgery Center Alliance in Fort Worth, Texas.

Dr. Araghizadeh's NPI, 1336236819, was assigned on October 6, 2006. Dr. Araghizadeh graduated from Frederick P. Whiddon College of Medicine in 1994. Dr. Araghizadeh's District of Columbia license number on file is MD036360.

Dr. Araghizadeh's primary practice is Medical City Surgery Center Alliance, at 8900 Medical City Way, Fort Worth, TX 76177. The practice phone is (817) 898-6610.

Dr. Araghizadeh's primary practice is Medical City Surgery Center Alliance in Fort Worth, Texas. Dr. Araghizadeh is also affiliated with Medical City Alliance Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Araghizadeh to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Araghizadeh practices, 4 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Araghizadeh's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Araghizadeh is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Araghizadeh's licenses on file in 4 states: District of Columbia, Texas, Maryland and Louisiana.

Dmand AI lists colonoscopy, colon removal and hemorrhoids among the conditions Dr. Araghizadeh treats.

CMS data shows 148 Medicare services from Dr. Araghizadeh across 5 procedure codes in 2024, for 91 Medicare patients. Medicare paid $22,423 for them. Every service was in an office.

CMS counts 91 Medicare patients who saw Dr. Araghizadeh in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Araghizadeh's median patient age at 56, with 51% women.

In 2024, Dr. Araghizadeh wrote 241 Medicare Part D claims for 87 patients. 76% of them were for generic drugs. CMS names the drug for 221 of them, across 6 drugs with 11 or more claims each, at $9,037 in total drug cost. In 2023, CMS named 191 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Araghizadeh for performance year 2024, reported as part of a group. Dr. Araghizadeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Araghizadeh in 2018. 2018 was the busiest year, with 2. The most frequent topics are Anal Canal. Dr. Araghizadeh's most frequent co-authors are Craig Howard Olson, MD, Yull Edwin Arriaga, MD and Nicole Mary Bedros, MD.

CMS Open Payments shows 463 general payments to Dr. Araghizadeh from 30 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Allergan Inc. paid the most, $178,727.

Dr. Araghizadeh graduated from Frederick P. Whiddon College of Medicine in 1994.

Dr. Araghizadeh is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.